Keyword: MSF

Here is some other vaccine news of note for the week.

Pfizer's Prevnar 13 is set for another price hike in 2018, according to Kaiser Health News.

Here is some other vaccine news of note for the week.

As it works toward its goal of eventually licensing a low-cost pneumonia vaccine, PnuVax will have a sum of money to lean on.

Health officials are in talks to deploy Merck & Co.’s experimental Ebola vaccine against a new outbreak in Congo.

Médecins Sans Frontières is empowering pharma investors to get involved in its fight to lower pneumococcal vaccine prices.

Patient-access groups that have targeted Gilead's Sovaldi IP all over the world are back on the attack in Europe.

MSF is taking an early step to mobilize Pfizer and GSK shareholders in its price-fighting effort by holding a “hackathon" in New York.

Indian drugmakers Natco and Alembic won permission to export their copies of two on-patent Bayer blockbusters to aid other would-be generics makers.

MSF took to social media on Valentine’s Day to call for further pneumonia vaccine price reductions in developing countries.